-
(1S,2S,13R,21R)-22-(cyclopropylmethyl)-11,14-dioxa-22-azaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5,7,9,15,17,19(25)-heptaene-2,16-diol methanesulfonic acid hydrate
-
ChemBase ID:
155544
-
Molecular Formular:
C27H31NO8S
-
Molecular Mass:
529.60194
-
Monoisotopic Mass:
529.17703796
-
SMILES and InChIs
SMILES:
CS(=O)(=O)O.c1ccc2c(c1)c1c(o2)[C@H]2[C@@]34CCN([C@@H]([C@@]3(C1)O)Cc1c4c(c(cc1)O)O2)CC1CC1.O
Canonical SMILES:
CS(=O)(=O)O.Oc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)Cc2c1oc1c2cccc1)CC1CC1.O
InChI:
InChI=1S/C26H25NO4.CH4O3S.H2O/c28-18-8-7-15-11-20-26(29)12-17-16-3-1-2-4-19(16)30-22(17)24-25(26,21(15)23(18)31-24)9-10-27(20)13-14-5-6-14;1-5(2,3)4;/h1-4,7-8,14,20,24,28-29H,5-6,9-13H2;1H3,(H,2,3,4);1H2/t20-,24+,25+,26-;;/m1../s1
InChIKey:
VAGWKZSGWSRENH-HIAJFTJMSA-N
-
Cite this record
CBID:155544 http://www.chembase.cn/molecule-155544.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
(1S,2S,13R,21R)-22-(cyclopropylmethyl)-11,14-dioxa-22-azaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5,7,9,15,17,19(25)-heptaene-2,16-diol methanesulfonic acid hydrate
|
|
|
|
|
IUPAC Traditional name
|
|
methanesulfonic acid naltriben hydrate
|
|
|
|
|
Synonyms
|
|
NTB hydrate
|
|
Naltriben methanesulfonate hydrate
|
|
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
10.112982
|
H Acceptors
|
4
|
H Donor
|
2
|
LogD (pH = 5.5)
|
0.5937983
|
LogD (pH = 7.4)
|
2.3634079
|
Log P
|
3.2100027
|
Molar Refractivity
|
115.5362 cm3
|
Polarizability
|
45.93531 Å3
|
Polar Surface Area
|
66.07 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
N156
|
Biochem/physiol Actions Naltriben methanesulfonate is a highly selective δ2 opioid receptor antagonist. The relative ability of the delta antagonists benzylidenenaltrexone and naltriben to inhibit DPDPE-stimulated [35S]GTPgammaS binding suggests that the opioid receptor is of the delta-2 subtype. Ligand binding assays demonstrates biphasic binding of the antagonist to the single receptor type. [35S]GTPgammaS binding is also stimulated by [D-Ser2,Leu5,Thr6]enkepha |
PATENTS
PATENTS
PubChem Patent
Google Patent